Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials
Authors' conclusion
Racial, ethnic, and geographic representation in IIM RCTs remains a critical issue.
Study context
- Population
- IIM randomized clinical trials (RCTs) published between 2010 to 2023
- Participants
- 19 RCTs
- Outcome
- Reporting and representation of race, ethnicity, sex and geography in IIM RCTs
Pooled result
As reported in the abstract
- Race appropriately reported
- 58%
- Black participants among enrollees
- 3%
- Asian participants among enrollees
- 7%
- Hispanic or Latino participants among enrollees
- 2%
- Ethnicity reported
- 26%
- Race and ethnicity conflated
- 16%
- Trials with >45% women participants
- 90%
- US sites in medically underserved areas (MUAs)
- 31%
- US sites in nonmetropolitan areas
- 0
- Sites in South America or Africa
- 0
Original publication
Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials. Arthritis Care Res (Hoboken). Published 3 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →